Immunomodulation as a Potent COVID-19 Pharmacotherapy: Past, Present and Future
Decsa Medika Hertanto,1,2 Bayu Satria Wiratama,3,4 Henry Sutanto,5,6 Citrawati Dyah Kencono Wungu7,8 1Department of Internal Medicine, Faculty of Medicine, Airlangga University, Surabaya, Indonesia; 2Department of Internal Medicine, Dr. Soetomo General Hospital, Surabaya, Indonesia; 3Department of E...
Guardado en:
Autores principales: | Hertanto DM, Wiratama BS, Sutanto H, Wungu CDK |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/7358f3b7506d475982ade76f50834948 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Educational Case: Burn Injury—Pathophysiology, Classification, and Treatment
por: Seth I. Noorbakhsh BA, et al.
Publicado: (2021) -
Pharmacogenomic Testing and Patient Perception Inform Pain Pharmacotherapy
por: Feng-Hua Loh, et al.
Publicado: (2021) -
BMSC-Derived Exosomes Ameliorate Osteoarthritis by Inhibiting Pyroptosis of Cartilage via Delivering miR-326 Targeting HDAC3 and STAT1//NF-κB p65 to Chondrocytes
por: Honggang Xu, et al.
Publicado: (2021) -
Cooling and Sterile Inflammation in an Oxygen-Glucose-Deprivation/Reperfusion Injury Model in BV-2 Microglia
por: Jana Lücht, et al.
Publicado: (2021) -
Topical Administration of 15-Deoxy-Δ12,14-Prostaglandin J2 Using a Nonionic Cream: Effect on UVB-Induced Skin Oxidative, Inflammatory, and Histopathological Modifications in Mice
por: Clovis M. Kumagai, et al.
Publicado: (2021)